Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Items 501–600 of 1,002
Predictors of Cardiovascular Autonomic Neuropathy in Patients with Type 1 Diabetes
Tannus, L. R. M., Drummond, K. R. G., Clemente, E. L. S., da Matta, M. D. F. B., Gomes, M. B., & Brazilian Type 1 Diabetes Study Group (BrazDiab1SG) (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00191 · Cited by 44
Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain
Watanabe, K., Hirano, S., Kojima, K., Nagashima, K., Mukai, H., Sato, T., Takemoto, M., Matsumoto, K., Iimori, T., Isose, S., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316601 · Cited by 45
Croosu, S. S., Røikjer, J., Mørch, C. D., Ejskjær, N., Frøkjær, J. B., & Hansen, T. M. (2022) · Diabetes Care · doi:10.2337/dc22-0587 · Cited by 42
New vistas in the diagnosis of diabetic polyneuropathy
Παπάνας, Ν., & Ziegler, D. (2014) · Endocrine · doi:10.1007/s12020-014-0285-z · Cited by 42
Zhang, Q., Ji, L., Zheng, H., Li, Q., Qian, X., Sun, W., Zhu, X., Li, Y., Lü, B., Liu, X., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.015 · Cited by 44
An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy
Azmi, S., Petropoulos, I. N., Ferdousi, M., Ponirakis, G., Alam, U., & Malik, R. A. (2019) · F1000Research · doi:10.12688/f1000research.17118.1 · Cited by 48
Self-citationSinclair, A. J., Dunning, T. L., Dhatariya, K., & an International Group of Experts (2019) · Diabetic Medicine · doi:10.1111/dme.14135 · Cited by 44
Cheng, Y., Cao, W., Zhang, J., Wang, J.-B., Liu, X., Wu, Q., & Lin, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934020 · Cited by 46
Heart Rate Variability and Sensorimotor Polyneuropathy in Type 1 Diabetes
Orlov, S., Bril, V., Orszag, A., & Perkins, B. A. (2012) · Diabetes Care · doi:10.2337/dc11-1652 · Cited by 43
Disautonomia: Uma Condição Esquecida – Parte 1
Rocha, E. A., Mehta, N., Távora‐Mehta, M. Z. P., Roncari, C. F., Cidrão, A. A. D. L., & Elías, J. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200420 · Cited by 50
Greco, C., Santi, D., Brigante, G., Pacchioni, C., & Simoni, M. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0314 · Cited by 43
“In particular, the cardiac autonomic neuropathy (CAN) is the manifestation of an ANS imbalance, due to the impairment of autonomic control of the cardiovascular system [1,2].”
Side and time variability of intraepidermal nerve fiber density
Lauria, G., Dacci, P., Lombardi, R., Cazzato, D., Porretta‐Serapiglia, C., Taiana, M. M., Sassone, J., Bella, E. D., Rinaldo, S., Lettieri, C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001666 · Cited by 44
Self-citationPatil, P. R., Wolfe, J., Said, Q., Thomas, J., & Martin, B. C. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000124 · Cited by 41
Nociception at the diabetic foot, an uncharted territory
Chantelau, E. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.391 · Cited by 46
TLR4 and Caveolin‐1 in Monocytes Are Associated With Inflammatory Conditions in Diabetic Neuropathy
Zhu, T., Meng, Q., Ji, J., Zhang, L., & Lou, X. (2016) · Clinical and Translational Science · doi:10.1111/cts.12434 · Cited by 40
Correlation between serum uric acid and diabetic peripheral neuropathy in T2DM patients
Lin, X., Xu, L., Zhao, D., Luo, Z., & Pan, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.11.034 · Cited by 41
Fang, F., Zhan, Y., Zhuo, Y., Yin, D., Li, K., & Wang, Y. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12646 · Cited by 40
Villarreal, C. F., Santos, D. S., Lauria, P. S. S., Gama, K. B., Santo, R. F. D. E., Juíz, P. J. L., Alves, C. Q., David, J. M., & Soares, M. B. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144850 · Cited by 48
“painful neuropathic symptoms, such as experience spontaneous prickling, stabbing or burning sensations, hyperalgesia and allodynia, and sensory loss, resulting in foot ulcerations and amputations [3,4].”
BackgroundInfluentialAbrams, R. M. C., Pedowitz, E., & Simpson, D. M. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1874920 · Cited by 40
“Patients may report burning, tingling, pins-andneedles, pricking, electric-shock, or deep aching sensations predominantly in the toes, feet, and legs [7,8].”
BackgroundInfluentialSmall Fiber Neuropathy in Diabetes Polyneuropathy: Is It Time to Change?
Sharma, S., Vas, P. R. J., & Rayman, G. A. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821996434 · Cited by 44
Edwards, K. P., Pritchard, N., Vagenas, D., Russell, A. W., Malik, R. A., & Efron, N. (2014) · Diabetic Medicine · doi:10.1111/dme.12466 · Cited by 39
Self-citationHuang, C., Lee, J., Lin, T., Tsai, N., Huang, C.-R., Chen, S.-F., Lu, C., & Liu, R. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6090749 · Cited by 39
“However, according to the report of expert panels on consensus of diabetic neuropathy in Toronto, age normative values should be used in testing cardiovascular autonomic function since age is the most important cofounding factor [5, 6].”
InfluentialVas, P. R. J., & EDMONDS, M. E. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30063-8 · Cited by 39
Validation and Reliability of the Portuguese Version of the Michigan Neuropathy Screening Instrument
Barbosa, M., Saavedra, A., Severo, M., Maier, C., & Carvalho, D. M. (2016) · Pain Practice · doi:10.1111/papr.12479 · Cited by 42
“Typically, diabetic polyneuropathy is a chronic, distal, symmetrical, length-dependent sensorimotor polyneuropathy (DSP), and it is thought to be the most common type.(1) Address correspondence and reprint requests to: Margarida Barbosa, BSRP, Department of Anesthesiology, Centro Hospitalar S~ ao Jo~ ao, Alameda Prof…”
BackgroundChu, C., Zhao, W., Zhang, Y., Li, L., Lu, J., Jiang, L., Wang, C., & Jia, W. (2016) · Scientific Reports · doi:10.1038/srep32623 · Cited by 40
“Exclusion criteria included: (1) missing data on age, sex, diabetes duration, and serum magnesium; (2) histories of persistent diarrhea or vomiting, progressive malignancy and severe renal insufficiency as defined by an eGFR < 60 ml·min−1·1.”
Walton, D. M., Minton, S. D., & Cook, A. D. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.07.003 · Cited by 41
Stubbs, E. B., Fisher, M. A., Miller, C. M., Jelinek, C. S., Butler, J., McBurney, C., & Collins, E. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00051 · Cited by 45
“Typical and atypical diabetic neuropathies (Tesfaye et al., 2010) are associated with considerable morbidity (including debilitating physical and psychosocial comorbidities) and mortality.”
BackgroundCarbajal-Ramírez, A., Hernández-Domínguez, J. A., Molina-Ayala, M., Rojas-Uribe, M. M., & Chávez-Negrete, A. J. (2019) · BMC Neurology · doi:10.1186/s12883-019-1332-4 · Cited by 39
Ciccacci, C., Latini, A., Colantuono, A., Politi, C., D’Amato, C., Greco, C., Rinaldi, M. E., Lauro, D., Novelli, G., Spallone, V., et al. (2020) · Epigenomics · doi:10.2217/epi-2019-0242 · Cited by 40
Self-citationChe, N., & Yang, H.-Q. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00204-3 · Cited by 35
Sierra‐Silvestre, E., Somerville, M., Bisset, L., & Coppieters, M. W. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001566 · Cited by 48
Venguidesvarane, A. G., Jasmine, A., Varadarajan, S., Shriraam, V., Muthuthandavan, A. R., Durai, V., Thiruvengadam, G., & Mahadevan, S. (2020) · Journal of Primary Care & Community Health · doi:10.1177/2150132720959962 · Cited by 39
Vilaça, T., Paggiosi, M., Walsh, J., Selvarajah, D., & Eastell, R. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4271 · Cited by 40
Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy
Kabir, M. T., Tabassum, N., Uddin, M. S., Aziz, F., Behl, T., Mathew, B., Rahman, M. H., Akter, R., Rauf, A., & Aleya, L. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9940169 · Cited by 41
“Nonetheless, certain people might contain pure small fiber neuropathy, which can lead to a loss of small fiber modalities (particularly pinprick and loss of temperature sensation) with normal large fiber activity [6].”
BackgroundDyck, P. J., Overland, C. J., Low, P. A., Litchy, W. J., Davies, J. L., Dyck, P. J., Carter, R. E., Melton, L. J., Andersen, H., Albers, J. W., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1481 · Cited by 39
Self-citationAssociation between visceral, cardiac and sensorimotor polyneuropathies in diabetes mellitus
Søfteland, E. W., Brock, C., Frøkjær, J. B., Brøgger, J. C., Madácsy, L., Gilja, O. H., Arendt‐Nielsen, L., Simrén, M., Drewes, A. M., & Dimcevski, G. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.10.009 · Cited by 39
“…more complicated with various tests being advocated, such as corneal confocal microscopy, quantitative sensory testing, laser Doppler imager flare, sudomotor tests and intraepidermal nerve fiber density (Papanas & Ziegler, 2011; Rage et al., 2011; Tesfaye et al., 2010; Vas, Green, & Rayman, 2012).”
BackgroundInfluentialGastrointestinal autonomic neuropathy in diabetes
Marathe, C. S., Jones, K. L., Wu, T., Rayner, C. K., & Horowitz, M. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102718 · Cited by 38
Self-citationAlpha-lipoic acid for diabetic peripheral neuropathy
Băicuş, C., Purcărea, A., von Elm, E. B., Delcea, C., & Furtunescu, F. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012967.pub2 · Cited by 52
Type 2 diabetes and cardiac autonomic neuropathy screening using dynamic pupillometry
Lerner, A. G., Bernabé‐Ortiz, A., Ticse, R., Hernandez, A. G., Huaylinos, Y., Pinto, M. E., Málaga, G., Checkley, W., Gilman, R. H., Miranda, J. J., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12752 · Cited by 40
No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy
de Greef, B. T. A., Hoeijmakers, J. G. J., Wolters, E. E., Smeets, H. J. M., van den Wijngaard, A., Merkies, I. S. J., Faber, C. G., & Gerrits, M. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148316 · Cited by 38
“The diagnosis SFN was made if patients fulfilled the criteria for SFN as described earlier [2, 24].”
MethodRisk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark
Andersen, S. T., Witte, D. R., Andersen, H., Bjerg, L., Bruun, N. H., Jørgensen, M. E., Finnerup, N. B., Lauritzen, T., Jensen, T. S., Tankişi, H., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0392 · Cited by 38
Dietary weight loss in people with severe obesity stabilizes neuropathy and improves symptomatology
Callaghan, B. C., Reynolds, E. L., Banerjee, M., Akıncı, G., Chant, E., Villegas‐Umana, E., Rothberg, A. E., Burant, C., & Feldman, E. L. (2021) · Obesity · doi:10.1002/oby.23246 · Cited by 40
“Clinical neuropathy was defined using the Toronto Consensus definition of probable polyneuropathy, which requires two or more of the following: neuropathy symptoms, abnormal sensory examination, and abnormal reflexes as determined by one of four neuromuscular specialists (22).”
MethodHaque, F., Reaz, M. B. I., Chowdhury, M. E. H., Ezeddin, M., Serkan Kiranyaz, B., Alhatou, M. I., Ali, S. H. M., Bakar, A. A. A., & Srivastava, G. (2022) · Sensors · doi:10.3390/s22093507 · Cited by 40
Diagnostic Accuracy of the Slump Test for Identifying Neuropathic Pain in the Lower Limb
Urban, L. M., & Macneil, B. J. (2015) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2015.5414 · Cited by 43
Stavniichuk, R., Shevalye, H., Hirooka, H., Nadler, J. L., & Obrosova, I. G. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.015 · Cited by 38
“DPN is manifested by nerve blood flow and motor (MNCV) and sensory (SNCV) nerve conduction velocity deficits as well as by increased vibration and thermal perception thresholds that progress to sensory loss, occurring in conjunction with degeneration of all fiber types in the peripheral nerve [4].”
Emerging drugs for diabetic peripheral neuropathy and neuropathic pain
Παπάνας, Ν., & Ziegler, D. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1257605 · Cited by 38
“It predominantly affects the distal parts of the lower (and, in advanced cases, also the upper) extremities [1,3].”
BackgroundYang, X., Yao, W., Li, Q., Liu, H., Shi, H., Gao, Y., & Xu, L. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.07.047 · Cited by 38
Reliability of heart rate variability in patients with Type 2 diabetes mellitus
Sacre, J. W., Jellis, C. L., Marwick, T. H., & Coombes, J. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03557.x · Cited by 37
Kelle, B., Evran, M., Ballı, T., & Yavuz, F. (2016) · Journal of Back and Musculoskeletal Rehabilitation · doi:10.3233/bmr-160676 · Cited by 37
Alternative Quantitative Tools in the Assessment of Diabetic Peripheral and Autonomic Neuropathy
Vinik, A. I., CASELLINI, C. M., & Névoret, M. L. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.03.010 · Cited by 44
“The Toronto Diabetic Neuropathy Expert Group defined DSPN as a symmetrical, length-dependent sensorimotor polyneuropathy attributable to metabolic, and microvascular alterations as a result of chronic hyperglycemia exposure (diabetes) and cardiovascular risk covariates (Tesfaye et al., 2010).”
BackgroundSelf-citationAlmurdhi, M. M., Brown, S. J., Bowling, F. L., Boulton, A. J. M., Jeziorska, M., Malik, R. A., & Reeves, N. D. (2017) · Diabetic Medicine · doi:10.1111/dme.13316 · Cited by 42
Self-citationAnemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients
Wu, F., Jing, Y., Tang, X., Li, D., Gong, L., Zhao, H., He, L., Li, Q., & Li, R. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1025-7 · Cited by 38
Ahmed, M. A., Muntingh, G. L., & Rheeder, P. (2017) · International Journal of Endocrinology · doi:10.1155/2017/2452853 · Cited by 47
“Diabetic peripheral neuropathy (DPN) is the most common complication, and it may eventually develop in up to 50% of patients [1].”
BackgroundHuang, R., Tian, S., Han, J., Lin, H., Guo, D., Wang, J., An, K., & Wang, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181126 · Cited by 40
“Diabetic peripheral neuropathy was defined as the presence of abnormal nerve conduction and a symptom or sign of neuropathy, as assessed using the Toronto Diabetic Neuropathy Expert Group [34].”
Computerized dynamic pupillometry as a screening tool for evaluation of autonomic activity
Sivakumar, A. V., Kalburgi-Narayana, M., Kuppusamy, M., Ramaswamy, P., & Bachali, S. (2020) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2020.09.004 · Cited by 37
Oh, T. J., Song, Y., Jang, H. C., & Choi, S. H. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0014 · Cited by 38
“A neurophysiological study is a confirmative test and is highly reproducible [7], and we diagnose confirmed DPN if the patient had symptom or sign of DPN with abnormality of the study [8].”
InfluentialCho, Y., Park, H. S., Huh, B. W., Seo, S., Seo, D. H., Ahn, S. H., Hong, S., Suh, Y. J., & Kim, S. H. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101389 · Cited by 42
Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects
Brouwer, B. A., de Greef, B. T. A., Hoeijmakers, J. G. J., Geerts, M., van Kleef, M., Merkies, I. S. J., & Faber, C. G. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0283-8 · Cited by 43
on behalf of the FinnDiane Study Group, Bernardi, L., Rosengård‐Bärlund, M., Sandelin, A. E., Mäkinen, V., Forsblom, C. M., & Groop, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2195-4 · Cited by 37
“Cardiovascular autonomic neuropathy was defined as the presence of two or more abnormal tests [26].”
BackgroundSelf-citationZiegler, D., Παπάνας, Ν., Roden, M., & for the GDC Study Group (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03345.x · Cited by 37
Oral alterations in diabetes mellitus
Cicmil, S., Mladenović, I., Krunić, J., Ivanović, D., & Stojanović, N. (2018) · Balkan Journal of Dental Medicine · doi:10.2478/bjdm-2018-0002 · Cited by 53
Screening for diabetic peripheral neuropathy in resource-limited settings
Nkonge, K. M., Nkonge, D. K., & Nkonge, T. N. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01032-x · Cited by 45
“2010 The Toronto Diabetic Neuropathy Expert Group proposes diagnostic criteria for possible, probable, confirmed, and subclinical diabetic neuropathy [36]”
BackgroundMochizuki, Y., Tanaka, H., Matsumoto, K., Sano, H., Toki, H., Shimoura, H., Ooka, J., Sawa, T., Motoji, Y., Ryo, K., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0213-4 · Cited by 36
A Clinical Decision Support System with an Integrated EMR for Diagnosis of Peripheral Neuropathy
Kunhimangalam, R., Ovallath, S., & Joseph, P. K. (2014) · Journal of Medical Systems · doi:10.1007/s10916-014-0038-9 · Cited by 43
“Symptoms often can be controlled, and eliminating the causes of specific forms of neuropathy often can prevent new damage while long-standing neuropathy may cause lasting nerve damage and generally reduces the chances of successful treatment [11].”
BackgroundSensory manifestations of diabetic neuropathies: Anatomical and clinical correlations
Kazamel, M., & Dyck, P. J. (2015) · Prosthetics and Orthotics International · doi:10.1177/0309364614536764 · Cited by 36
Self-citationNeurovascular Function and Sudorimetry in Health and Disease
Vinik, A. I., Névoret, M. L., CASELLINI, C. M., & Parson, H. K. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0392-x · Cited by 37
Self-citationHistamine in diabetes: Is it time to reconsider?
Pini, A., Obara, I., Battell, E. E., Chazot, P. L., & Rosa, A. C. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.021 · Cited by 38
Epidermal Nerve Fiber Quantification in Patients With Erythromelalgia
Mantyh, W. G., Dyck, P. J. B., Dyck, P. J. B., Engelstad, J. K., Litchy, W. J., Sandroni, P., & Davis, M. D. P. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.4404 · Cited by 38
Self-citationYan, A., Issar, T., Tummanapalli, S. S., Markoulli, M. P., Kwai, N. C. G., Poynten, A. M., & Krishnan, A. V. (2019) · Diabetic Medicine · doi:10.1111/dme.13952 · Cited by 36
Diabetic Autonomic Neuropathy: A Clinical Update
Sharma, J. K., Rohatgi, A., & Sharma, D. (2020) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2020.310 · Cited by 39
Ferdousi, M., Kalteniece, A., Azmi, S., Petropoulos, I. N., Worthington, A., D’Onofrio, L., Dhage, S. S., Ponirakis, G., Alam, U., Marshall, A. G., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001801 · Cited by 37
Self-citationHaque, F., Reaz, M. B. I., Chowdhury, M. E. H., Srivastava, G., Ali, S. H. M., Bakar, A. A. A., & Bhuiyan, M. A. S. (2021) · Diagnostics · doi:10.3390/diagnostics11050801 · Cited by 39
“NCS is considered as the benchmark for the identification and stratification of DSPN [9].”
BackgroundZinc deficiency correlates with severity of diabetic polyneuropathy
Hussein, M., Fathy, W., Hassan, A., Elkareem, R. M. A., Marzouk, S., & Kamal, Y. S. (2021) · Brain and Behavior · doi:10.1002/brb3.2349 · Cited by 40
Novel Autoantibodies in Idiopathic Small Fiber Neuropathy
Chan, A. C. Y., Wong, H. Y., Chong, Y. F. V., Lai, P. S., Teoh, H. L., Ng, A. Y. Y., Hung, J. H. M., Chan, Y. C., Ng, K. W. P., Vijayan, J., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26268 · Cited by 37
Meng, Y., Preston, F., Ferdousi, M., Azmi, S., Petropoulos, I. N., Kaye, S. B., Malik, R. A., Alam, U., & Zheng, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041284 · Cited by 38
“PN was defined according to the Toronto consensus on diabetic neuropathy [8] and pre-diabetes was defined using WHO/ADA criteria.”
MethodSelf-citationMerecz-Sadowska, A., Markiewicz, Ł., Śliwińska, A., Kosmalski, M., Kasznicki, J., Drzewoski, J., & Majsterek, I. (2015) · Advances in Medical Sciences · doi:10.1016/j.advms.2015.04.001 · Cited by 36
Obrosova (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.597 · Cited by 36
Fleischer, J., Cichosz, S. L., Høyem, P., Laugesen, E., Poulsen, P. L., Christiansen, J. S., Tarnow, L., & Hansen, T. K. (2015) · Diabetes Care · doi:10.2337/dc14-0654 · Cited by 37
Buraczyńska, M., Buraczyńska, K., Dragan, M., & Książek, A. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8438-2 · Cited by 37
“Diabetic neuropathy was diagnosed by clinical neurological examination and electromyography (Viking Select EMG System, Nicolet Biomedical, USA) according to the recent guidelines (Tesfaye et al. 2010).”
Zafrir, B., Azencot, M., Dobrecky‐Mery, I., Lewis, B. S., Flugelman, M. Y., & Halon, D. A. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315624747 · Cited by 38
“Screening for cardiac autonomic dysfunction is recommended in asymptomatic type 2 diabetes, and clinical diagnosis is established on at least two abnormal CART tests, which are based on HR and blood pressure response to several manoeuvres.(25) Although CART-based diagnosis is recommended for screening patients with di…”
BackgroundNeuronal Changes in the Diabetic Cornea: Perspectives for Neuroprotection
Мухаррамовна, Б. Г., Oshitari, T., Baba, T., & Yamamoto, S. (2016) · BioMed Research International · doi:10.1155/2016/5140823 · Cited by 35
“Diabetic neuropathies characterized by a progressive loss of nerve fibers are common complications affecting about 50% of patients with diabetes [1].”
BackgroundDidangelos, T., Τζιόμαλος, Κ., Margaritidis, C., Kontoninas, Z., Stergiou, I., Tsotoulidis, S., Karlafti, E., Mourouglakis, A., & Hatzitolios, A. I. (2017) · Journal of Diabetes Research · doi:10.1155/2017/6719239 · Cited by 36
Tentolouris, A., Eleftheriadou, I., Grigoropoulou, P., Kokkinos, A. D., Siasos, G., Ntanasis‐Stathopoulos, I., & Tentolouris, N. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.07.010 · Cited by 36
Mrakic‐Sposta, S., Vezzoli, A., Maderna, L., Gregorini, F., Montorsi, M., Moretti, S. D. A., Greco, F., Cova, E., & Gussoni, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1767265 · Cited by 36
“Painful DN deleteriously influences quality of life, sleep, mood, and the ability to work [16, 17].”
BackgroundChronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study
Moorthi, R. N., Doshi, S., Fried, L. F., Moe, S. M., Sarnak, M. J., Satterfield, S., Schwartz, A. V., Shlipak, M. G., Lange‐Maia, B. S., Harris, T. B., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy102 · Cited by 35
Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status
Guo, K., Savelieff, M. G., Rumora, A. E., Alakwaa, F., Callaghan, B. C., Hur, J., & Feldman, E. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab844 · Cited by 35
Obesity-Associated Neuropathy: Recent Preclinical Studies and Proposed Mechanisms
Bonomo, R. R., Krämer, S., & Mansuy‐Aubert, V. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0278 · Cited by 44
Artificial Intelligence and Corneal Confocal Microscopy: The Start of a Beautiful Relationship
Alam, U., Anson, M., Meng, Y., Preston, F., Kirthi, V., Jackson, T. L., Nderitu, P., Cuthbertson, D. J., Malik, R. A., Zheng, Y., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206199 · Cited by 38
“has been extensively studied in DPN (Table 1) [33].”
BackgroundSelf-citationMeasurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy
Kukidome, D., Nishikawa, T., Sato, M., Igata, M., Kawashima, J., Shimoda, S., Matsui, K., Obayashi, K., Ando, Y., & Araki, E. (2015) · Diabetic Medicine · doi:10.1111/dme.12797 · Cited by 42
EMLA-Induced Skin Wrinkling for the Detection of Diabetic Neuropathy
Ng, K. W. P., Ong, J. J. Y., Nyein, T. D. N., Shen, L., Chan, Y. C., Lee, K., & Wilder-Smith, E. P. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00126 · Cited by 35
Pai, Y., Lin, C., Lee, I., & Chang, M. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.01.015 · Cited by 38
Valer, T. L. M., Mujica, L. F. P., Corcuera‐Ciudad, R., Terry, F., Chevarría-Arriaga, M. J., Vasquez-Hassinger, T., & Yovera-Aldana, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284054 · Cited by 42
“Subclinical PN when there is only abnormal nervous conduction test [56].”
BackgroundMäättä, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Kühle, J., Tankişi, H., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2208 · Cited by 34
Diabetic Peripheral Neuropathy: Emerging Treatments of Neuropathic Pain and Novel Diagnostic Methods
Røikjer, J., Borbjerg, M. K., Andresen, T., Giordano, R., Hviid, C. V. B., Mørch, C. D., Karlsson, P., Klonoff, D. C., Arendt‐Nielsen, L., & Ejskjær, N. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241279553 · Cited by 43
“93,94 Nerve conduction study is performed by activating a defined sensory or motor nerve and assessing the compound action potential by surface electrodes.”
Serum albumin is associated with peripheral nerve function in patients with type 2 diabetes
Li, L., Liu, B., Lu, J., Jiang, L., Zhang, Y., Shen, Y., Wang, C., & Jia, W. (2015) · Endocrine · doi:10.1007/s12020-015-0588-8 · Cited by 34
Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review
Lekoubou, A., Matsha, T. E., Sobngwi, E., & Kengne, A. P. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-171 · Cited by 34
Yun, J., Cha, S., Lim, T., Lee, E.-Y., Song, K., Ahn, Y., Yoo, K., Kim, J., Park, Y., & Ko, S. (2016) · Medicine · doi:10.1097/md.0000000000003128 · Cited by 35
“The CAN staging scores of 0 were defined as normal autonomic function, while scores of 1 and 2 or more were defined as early CAN and definite CAN, respectively.(18,19)”
MethodBone Microarchitecture in Type 1 Diabetes: It Is Complicated
Keenan, H. A., & Maddaloni, E. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0338-8 · Cited by 34
Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy
Sai Laxmi, M., & Orsu, P. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00734-1 · Cited by 38
Stepping Back to Minimal Footwear: Applications Across the Lifespan
Davis, I. S., Hollander, K., Lieberman, D. E., Ridge, S. T., Sacco, I. D. C. N., & Wearing, S. C. (2021) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000263 · Cited by 37
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.